CV Sciences (CVSI) Short Interest Ratio & Short Volume → It’s now possible to know the win rate of every trade… BEFORE you take it! (From WealthPress) (Ad) Free CVSI Stock Alerts $0.04 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest CV Sciences Short Interest DataCurrent Short Volume67,700 sharesPrevious Short Volume27,600 sharesChange Vs. Previous Month+145.29%Dollar Volume Sold Short$2,525.21Short Interest Ratio / Days to Cover0.1Last Record DateApril 15, 2024Outstanding Shares163,228,000 sharesPercentage of Shares Shorted0.04%Today's Trading Volume46,553 sharesAverage Trading Volume223,673 sharesToday's Volume Vs. Average21% Short Selling CV Sciences ? Sign up to receive the latest short interest report for CV Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCVSI Short Interest Over TimeCVSI Days to Cover Over TimeCVSI Percentage of Float Shorted Over Time Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. CV Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202467,700 shares $2,525.21 +145.3%N/A0.1 $0.04 3/31/202427,600 shares $1,131.60 +305.9%N/A0 $0.04 3/15/20246,800 shares $233.58 -21.8%N/A0 $0.03 2/29/20248,700 shares $305.37 -23.7%N/A0 $0.04 2/15/202411,400 shares $424.08 -60.8%N/A0 $0.04 1/15/202411,400 shares $432.06 +78.1%N/A0 $0.04 Get the Latest News and Ratings for CVSI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CV Sciences and its competitors with MarketBeat's FREE daily newsletter. 12/31/20236,400 shares $226.24 -68.0%N/A0 $0.04 12/15/202320,000 shares $689.60 +8.1%N/A0 $0.03 11/30/202318,500 shares $669.70 +74.5%N/A0 $0.04 11/15/202310,600 shares $340.26 No ChangeN/A0 $0.03 10/31/202310,600 shares $392.20 No ChangeN/A0 $0.04 10/15/202310,600 shares $446.26 -5.4%N/A0 $0.04 9/30/202311,200 shares $529.20 -71.3%N/A0 $0.05 9/15/202339,000 shares $1,950.00 +60.5%N/A0 $0.05 8/31/202324,300 shares $1,020.60 +129.3%N/A0.1 $0.04 8/15/202310,600 shares $418.70 -59.4%N/A0 $0.04 7/31/202326,100 shares $1,137.96 +146.2%N/A0.1 $0.04 7/15/202310,600 shares $530.00 -3.6%N/A0 $0.05 6/30/202311,000 shares $444.40 -26.7%N/A0.1 $0.04 6/15/202315,000 shares $646.50 -42.5%N/A0.1 $0.04 5/31/202326,100 shares $1,174.50 -39.9%N/A0.1 $0.05 5/15/202343,400 shares $1,835.82 +20.2%N/A0.1 $0.04 4/30/202336,100 shares $1,691.29 +132.9%N/A0.1 $0.05 4/15/202315,500 shares $674.25 +46.2%N/A0.1 $0.04 3/31/202310,600 shares $455.80 No ChangeN/A0 $0.04 3/15/202310,600 shares $434.60 -8.6%N/A0 $0.04 2/28/202311,600 shares $545.20 -76.2%N/A0 $0.05 2/15/202348,700 shares $2,775.90 -94.7%N/A0.1 $0.06 1/31/2023924,300 shares $35,585.55 -47.2%N/A0.7 $0.04 1/15/20231,750,200 shares $58,719.21 -0.6%N/A7.5 $0.03 12/30/20221,760,800 shares $57,049.92 -11.2%N/A1 $0.03 12/15/20221,982,500 shares $64,431.25 -5.9%N/A2.9 $0.03 11/30/20222,106,800 shares $79,005.00 -7.4%N/A3 $0.04 11/15/20222,274,400 shares $89,838.80 -0.9%N/A2.8 $0.04 10/31/20222,295,700 shares $89,532.30 -0.7%N/A2.5 $0.04 10/15/20222,311,500 shares $86,912.40 No ChangeN/A2.2 $0.04 9/30/20222,311,500 shares $94,771.50 -7.1%N/A2.7 $0.04 9/15/20222,489,000 shares $124,450.00 +17.0%N/A1.7 $0.05 8/31/20222,127,900 shares $112,991.49 +40.7%N/A0.5 $0.05 8/15/20221,512,600 shares $44,772.96 -5.3%N/A0.8 $0.03The A.I. story nobody is telling you (Read ASAP) (Ad)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. CVSI Short Interest - Frequently Asked Questions What is CV Sciences' current short interest? Short interest is the volume of CV Sciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 67,700 shares of CVSI short. Learn More on CV Sciences' current short interest. Is CV Sciences' short interest increasing or decreasing? CV Sciences saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 67,700 shares, an increase of 145.3% from the previous total of 27,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does CV Sciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to CV Sciences: Ainos, Inc. (2.84%), Vaccinex, Inc. (2.99%), First Wave BioPharma, Inc. (2.05%), Kazia Therapeutics Limited (0.11%), Avenue Therapeutics, Inc. (0.44%), Xenetic Biosciences Inc (0.22%), Theriva Biologics, Inc. (2.35%), Integrated BioPharma, Inc. (0.00%), Shuttle Pharmaceuticals Holdings, Inc. (0.77%), Enveric Biosciences, Inc. (1.40%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short CV Sciences stock? Short selling CVSI is an investing strategy that aims to generate trading profit from CV Sciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CV Sciences? A short squeeze for CV Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CVSI, which in turn drives the price of the stock up even further. How often is CV Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CVSI, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: AIMD Short Squeeze VCNX Short Squeeze FWBI Short Squeeze KZIA Short Squeeze ATXI Short Squeeze XBIO Short Squeeze TOVX Short Squeeze INBP Short Squeeze SHPH Short Squeeze ENVB Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:CVSI) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings